Skip to main content
letter
. 2016 Mar 7;51(7):994–996. doi: 10.1038/bmt.2016.4

Figure 1.

Figure 1

(a) Overall survival (OS) of all analyzed patients. (b) OS according to remission status. (c) OS of patients who developed cGvHD with bone marrow disease but no extramedullary disease.